Medical physics

International Isotopes Inc. Announces It Has Acquired Full Ownership Of RadQual LLC

Retrieved on: 
Monday, July 12, 2021

In August 2017, this group of sellers acquired all of the units of RadQual not already held by INIS.

Key Points: 
  • In August 2017, this group of sellers acquired all of the units of RadQual not already held by INIS.
  • With this most recent acquisition, INIS will now own 100% of all outstanding units of RadQual, making RadQual a wholly-owned subsidiary of INIS.
  • RadQual is the premier global developer of quality control products for the nuclear medicine industry, focused principally on SPECT and PET imaging.
  • From RadQual 's inception in 2001, INIS has been the sole contract manufacturer of all RadQual products.

HistoSonics Announces Milestone As American Medical Association Issues Unique Category III CPT® Code For Histotripsy Of Liver

Retrieved on: 
Monday, July 12, 2021

MINNEAPOLIS, July 12, 2021 /PRNewswire/ -- HistoSonics, ( www.histosonics.com ), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, is pleased to announce that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT) code for histotripsy of the liver.

Key Points: 
  • MINNEAPOLIS, July 12, 2021 /PRNewswire/ -- HistoSonics, ( www.histosonics.com ), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, is pleased to announce that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT) code for histotripsy of the liver.
  • Histotripsy of the liver provides clinicians the first automated external beam therapy using acoustic energy to mechanically destroy tissue in the liver without incisions, ionizing radiation or heat.
  • The new CPT code will become effective on January 1, 2022, at which time providers can utilize the code when performing histotripsy procedures on patients across the United States.
  • The new Category III CPT code, 0686T Histotripsy (ie, non-thermal ablation via acoustic energy delivery) of malignant hepatocellular tissue, including image guidance will become effective January 1, 2022.

Global Nuclear Imaging Equipment Market Competition Forecast & Opportunities, 2021-2026 - PET Imaging Systems, Gamma Camera Imaging Systems - ResearchAndMarkets.com

Retrieved on: 
Monday, July 12, 2021

The "Global Nuclear Imaging Equipment Market, By Type (PET Imaging Systems, Gamma Camera Imaging Systems), By Gamma Camera Imaging Systems, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Nuclear Imaging Equipment Market, By Type (PET Imaging Systems, Gamma Camera Imaging Systems), By Gamma Camera Imaging Systems, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.
  • The Global Nuclear Imaging Equipment Market stood at USD4.05 billion in 2020 and is expected to grow at a steady CAGR of 6.51% to 2026.
  • The growing focus on personalized medicines is further expected to spur the growth of the Global Nuclear Imaging Equipment Market during the next five years.
  • Nuclear imaging equipment aids in treatment process thereby contributing to increase in the demand for the nuclear imaging equipment market.

Global Diagnostic Imaging Markets to 2026: Ultrasound Systems, Nuclear Imaging Systems, X-Ray, CT Scanner, MRI, Mammography System, Fluoroscopy - ResearchAndMarkets.com

Retrieved on: 
Friday, July 9, 2021

Global Diagnostic Imaging Market was valued USD32.631 billion in 2019 and is forecast to grow to grow at CAGR of 7.72% during the forecast period.

Key Points: 
  • Global Diagnostic Imaging Market was valued USD32.631 billion in 2019 and is forecast to grow to grow at CAGR of 7.72% during the forecast period.
  • The Global Diagnostic Imaging Market is segmented on the basis of product type, systems, portability, applications, end-users and region.
  • The System segment is segregated into Ultrasound Systems, Nuclear Imaging Systems, X-Ray Imaging Systems, CT Scanners, MRI Systems, Mammography Systems and Fluoroscopy.
  • In terms of regional analysis, the Global Diagnostic Imaging Market is segregated into Asia-Pacific, Europe, North America, South America, and Middle East & Africa.

NCCN Maintains Qualification as CMS-Approved Provider-Led Entity for the Development of Imaging Appropriate Use Criteria

Retrieved on: 
Wednesday, July 7, 2021

NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC) are accessible for free to registered users of NCCN.org through an easy-to-use database at NCCN.org/ImagingAUC .

Key Points: 
  • NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC) are accessible for free to registered users of NCCN.org through an easy-to-use database at NCCN.org/ImagingAUC .
  • "NCCN is honored to remain among the distinguished group of CMS-approved provider-led entities for development of diagnostic imaging AUC," said Robert W. Carlson, MD, Chief Executive Officer, NCCN.
  • NCCN Imaging AUC are based directly on the NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ) and include recommendations pertaining to cancer screening, diagnosis, staging, treatment response assessment, follow-up, and surveillance.
  • All imaging procedures recommended in the NCCN Guidelines, including radiographs, computed tomography (CT) scans, magnetic resonance imaging (MRI), functional nuclear medicine imaging (PET, SPECT) and ultrasound, are included within NCCN Imaging AUC.

XIFIN Enters Radiology RCM Services Segment with Computerized Management Services Acquisition

Retrieved on: 
Wednesday, July 7, 2021

XIFIN today announced the acquisition of Computerized Management Services (CMS), a provider of revenue cycle management (RCM) services for radiology groups and imaging centers.

Key Points: 
  • XIFIN today announced the acquisition of Computerized Management Services (CMS), a provider of revenue cycle management (RCM) services for radiology groups and imaging centers.
  • The combined organization will provide robust healthcare technology services across diagnostic markets including radiology, pathology, oncology, digital health, and laboratory.
  • This acquisition positions XIFIN firmly in the diagnostic imaging market, estimated to be over $100 billion in the U.S.
  • Through this deal, CMS will become a subsidiary of XIFIN, and Favale will continue to lead CMS as general manager, XIFIN Radiology Services.

NMS Capital Announces Partnership and Investment in DirectMed Parts & Service

Retrieved on: 
Wednesday, July 7, 2021

NMS Capital (NMS) announced today that it has partnered with Company management in the recapitalization of DirectMed Parts & Service, LLC (DirectMed or the Company).

Key Points: 
  • NMS Capital (NMS) announced today that it has partnered with Company management in the recapitalization of DirectMed Parts & Service, LLC (DirectMed or the Company).
  • Headquartered in San Diego, CA, DirectMed is the largest independent source for service and supply of medical imaging parts for MRI and CT machines.
  • NMS is excited to partner with the DirectMed team given our shared vision in building upon their leadership position in the imaging parts and service sector.
  • DirectMed Parts & Service is the largest independent diagnostic imaging parts supplier specializing in MRI and CT machines with over 60,000 parts in stock.

RamSoft Acquires a Majority Stake in Meddiff to Advance Patient Care Globally

Retrieved on: 
Tuesday, July 6, 2021

RamSoft will continue to be headquartered in Toronto, Canada and the company's management team will be led by President and CEO Vijay Ramanathan.

Key Points: 
  • RamSoft will continue to be headquartered in Toronto, Canada and the company's management team will be led by President and CEO Vijay Ramanathan.
  • "Our commitment to saving patient lives through universal access to imaging is what drives us as a company.
  • To expand its global footprint and support this mission, RamSoftlooked towards Meddiff, a Bangalore-based company that has over 1,500 installed sites globally.
  • Built using cutting-edge, single database technology, our radiology, mammography, and enterprise imaging software enables practices tooptimize their workflow, cut costs, and overall, improve patient care.

RamSoft Acquires a Majority Stake in Meddiff to Advance Patient Care Globally

Retrieved on: 
Tuesday, July 6, 2021

RamSoft will continue to be headquartered in Toronto, Canada and the company's management team will be led by President and CEO Vijay Ramanathan.

Key Points: 
  • RamSoft will continue to be headquartered in Toronto, Canada and the company's management team will be led by President and CEO Vijay Ramanathan.
  • "Our commitment to saving patient lives through universal access to imaging is what drives us as a company.
  • To expand its global footprint and support this mission, RamSoftlooked towards Meddiff, a Bangalore-based company that has over 1,500 installed sites globally.
  • Built using cutting-edge, single database technology, our radiology, mammography, and enterprise imaging software enables practices tooptimize their workflow, cut costs, and overall, improve patient care.

Nanox to Present at the Ladenburg Thalmann Healthcare Conference

Retrieved on: 
Thursday, July 1, 2021

Mr. Poliakines presentation is scheduled for Wednesday, July 14, at 10:00am ET.

Key Points: 
  • Mr. Poliakines presentation is scheduled for Wednesday, July 14, at 10:00am ET.
  • Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the Company's website at www.nanox.vision .
  • Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications.
  • Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all.